What is Miqnaf (Nafithromycin) and its application?
Drug Approval & Key Details In a significant stride for India’s pharmaceutical and healthcare sectors, Miqnaf (Nafithromycin), developed by Wockhardt, has been approved by the Central Drugs Standard Control Organization (CDSCO) for the treatment of Community-Acquired Bacterial Pneumonia (CABP) in adults. This approval marks the first new macrolide-based treatment for CABP in India in nearly 30 years, addressing the growing challenge of … Read more